Roche RHHBY
announced today the U.S. availability of a new HIV-1 viral load test based on
the company's proprietary dual-target approach. The COBAS TaqMan HIV-1 Test
v2.0 for use with the High Pure System enables labs to combine an FDA-approved
process for manual specimen preparation with an automated real-time PCR
analyzer for amplification and detection.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in